Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016.
O'Toole Á. et al, (2023), Science (New York, N.Y.), 382, 595 - 600
Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study.
Otiende M. et al, (2023), Nature communications, 14
Distinct monkeypox virus lineages co-circulating in humans before 2022.
Ndodo N. et al, (2023), Nat Med, 29, 2317 - 2324
Enablers and barriers to COVID-19 vaccine uptake in an urban slum in Lagos, Nigeria: informing vaccine engagement strategies for the marginalized.
Ozoh OB. et al, (2023), International health, 15, 557 - 565
National prevalence and risk factors for tungiasis in Kenya.
Elson L. et al, (2023), Infectious diseases of poverty, 12
A long-term observational study of paediatric snakebite in Kilifi County, south-east Kenya.
Abouyannis M. et al, (2023), PLoS neglected tropical diseases, 17
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys.
Gallagher KE. et al, (2023), The Lancet. Infectious diseases
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study.
Bochner AF. et al, (2023), The Lancet. Global health, 11, e871 - e879
Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world.
Adetifa I. et al, (2023), Lancet (London, England), 401, 1822 - 1824
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria.
Adamu AL. et al, (2023), Nature communications, 14
Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.
Ochu CL. et al, (2023), Scientific reports, 13
Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
Tohme RA. et al, (2023), Vaccines (Basel), 11
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria.
Olawoye IB. et al, (2023), Nature communications, 14
SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: Implications for epidemic control.
Adeyemi OO. et al, (2023), PloS one, 18
Pulmonary non-tuberculous mycobacteria in colonisation and disease in The Gambia.
Okoi C. et al, (2022), Scientific reports, 12
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.
Tegally H. et al, (2022), Science (New York, N.Y.), 378
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
Ojal J. et al, (2022), Wellcome Open Research, 6, 127 - 127